<DOC>
	<DOCNO>NCT01619462</DOCNO>
	<brief_summary>The study aim evaluate safety immunogenicity 10-valent 13-valent pneumococcal conjugate vaccine administer accelerated schedule Papua New Guinean child , experience early dense upper respiratory tract colonisation broad range pneumococcal serotypes , compare antibody titre follow booster dose polysaccharide vaccine 9 month child receive booster age .</brief_summary>
	<brief_title>Safety Immunogenicity 10-valent 13-valent Pneumococcal Conjugate Vaccines Papua New Guinean Children</brief_title>
	<detailed_description>The primary aim study determine whether PCV10 PCV13 safe immunogenic PNG infant serotypes respective vaccine . This study important follow reason : 1 . There lack data worldwide immunogenicity population high early onset dense URT carriage . 2 . The EPI immunisation schedule accelerate PNG ( age 1,2 3 month ) . 3 . There data functional antibody PCVs PNG . 4 . There data NTHi Protein D antibody responses PNG worldwide population high URT carriage rate young age , i.e . likely benefit vaccine include NTHi protein carrier . 5 . It important investigate impact vaccine carriage density view find limited impact 7vPCV URT carriage . 6 . There data antibody responses follow 10v 13v PCV booster PPV young 9 month age ( would appropriate within current PNG EPI schedule many third world country ) . 7 . There data antibody response ( include functional assay ) 23vPPV challenge age 2 year 23vPPV booster age 9 month child prim PCV . 8 . The broad range serotypes cause IPD PNG necessitate continue consideration 23vPPV potential booster age 9 month . 9 . Serotype-specific B cell memory important aspect test address immunological safety PPV child prim PCV . 10 . The Global Alliance Vaccines Immunisation ( GAVI ) World Health Organisation ( WHO ) commit introduction PCV infants GAVI-eligible country ( include PNG ) use novel funding mechanism . In PNG , introduction PCV plan 2013 .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Health infant 28 35 day old Infants woman intend remain least two year Birth weigh &lt; 2000 g ( 2kg ) Severe congenital abnormality Mother child know HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>35 Days</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>pneumococcal</keyword>
	<keyword>vaccine</keyword>
	<keyword>papua new guinea</keyword>
</DOC>